FoundationOne Heme is a comprehensive genomic profiling test developed by Foundation Medicine, specifically tailored for haematologic malignancies such as leukaemia, lymphoma, and myeloma. This test uses next-generation sequencing to analySe DNA and RNA from tumour specimens. It identifies clinically actionable genomic alterations which can enhance the ability to make informed decisions about patient care.